Abstract
BackgroundSafety of paediatric pharmacotherapy is of major concern. Due to high off-label use (about 46–64% of patients in primary care are affected), missing paediatric dosage forms and complex dosage calculations,...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Archives of disease in childhood. Fetal and neonatal edition
Paper Title
Journal
Date
